Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhadran Bose

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|November 21, 2022
Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatmentEdmund Y M Chung, Yuan M Wang, Karen Keung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Effect of dialysis modality on survival of hepatitis C-infected ESRF patientsBhadran Bose, Stephen P McDonald, Carmel M Hawley, et al.
Kidney International Reports|August 24, 2019
Adenine Phosphoribosyltransferase Deficiency: A Potentially Reversible Cause of CKDJennifer Li, Meena Shingde, Brian J Nankivell, et al.
Internal Medicine Journal|April 11, 2025
Glomerular disease registry and biobank: design and baseline resultsAndrew Jeyaruban, Bhadran Bose, Vincent W Lee, et al.
Transplantation Direct|August 8, 2022
Predictive Models for Recurrent Membranous Nephropathy After Kidney TransplantationEdmund Y M Chung, Katrina Blazek, Armando Teixeira-Pinto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2013
The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New ZealandWen Tang, Bhadran Bose, Stephen P McDonald, et al.
Kidney International Reports|April 30, 2025
Erratum to "Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome" [<i>Kidney International Reports</i> Volume 9, Issue 10, October 2024, Pages 3053-3056]David Massicotte-Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
Kidney International Reports|October 21, 2024
Anticoagulation for the Prevention of Thrombotic Events in Nephrotic SyndromeDavid Massicotte Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 24, 2025
Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview StudyEdmund Y M Chung, Simon A Carter, Allison Jaure, et al.
Nephrology (Carlton, Vic.)|May 8, 2020
Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registryJacqueline Soraru, Nicole Isbel, Germaine Wong, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|November 21, 2022
Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatmentEdmund Y M Chung, Yuan M Wang, Karen Keung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Effect of dialysis modality on survival of hepatitis C-infected ESRF patientsBhadran Bose, Stephen P McDonald, Carmel M Hawley, et al.
Kidney International Reports|August 24, 2019
Adenine Phosphoribosyltransferase Deficiency: A Potentially Reversible Cause of CKDJennifer Li, Meena Shingde, Brian J Nankivell, et al.
Internal Medicine Journal|April 11, 2025
Glomerular disease registry and biobank: design and baseline resultsAndrew Jeyaruban, Bhadran Bose, Vincent W Lee, et al.
Transplantation Direct|August 8, 2022
Predictive Models for Recurrent Membranous Nephropathy After Kidney TransplantationEdmund Y M Chung, Katrina Blazek, Armando Teixeira-Pinto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2013
The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New ZealandWen Tang, Bhadran Bose, Stephen P McDonald, et al.
Kidney International Reports|April 30, 2025
Erratum to "Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome" [<i>Kidney International Reports</i> Volume 9, Issue 10, October 2024, Pages 3053-3056]David Massicotte-Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
Kidney International Reports|October 21, 2024
Anticoagulation for the Prevention of Thrombotic Events in Nephrotic SyndromeDavid Massicotte Azarniouch, Daniel J Crona, Priscilla Karnabi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 24, 2025
Patients' Perspectives on Living With Primary Membranous Nephropathy: A Semi-Structured Interview StudyEdmund Y M Chung, Simon A Carter, Allison Jaure, et al.
Nephrology (Carlton, Vic.)|May 8, 2020
Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registryJacqueline Soraru, Nicole Isbel, Germaine Wong, et al.
Pageof 4